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Abstract: Background: Metastatic infections such as infective endo-
carditis and psoas abscess are serious complications of Staphylococcus
aureus bacteremia because failure to identify these infections may result
in bacteremia relapse or poor prognosis. In the present study, we deter-
mined the predictive factors for metastatic infection due to methicillin-
sensitive S. aureus bacteremia. Methods: A retrospective cohort study
was conducted among patients with methicillin-sensitive S. aureus bac-
teremia at the Jikei University Hospital between January 2008 and
December 2012. Factors analyzed included the underlying disease,
initial antimicrobial treatment and primary site of infection.
Results: During the 5-year study period, 73 patients met the inclusion
criteria and were assessed. The most common primary site of
bacteremia was catheter-related bloodstream infection (25/73
[34.2%]). Metastatic infection occurred in 14 of 73 patients (19.2%)
(infective endocarditis [3], septic pulmonary abscess [3], spondylitis [4],
psoas abscess [4], epidural abscess [3] and septic arthritis [1]). Six
patients had multiple metastatic infections. Multivariate analysis
revealed that the predictive factors associated with the development
of metastatic infection were a delay in appropriate antimicrobial
treatment of .48 hours, persistent fever for .72 hours after starting
antibiotic treatment and lowest C-reactive protein levels of .3 mg/dL
during 2 weeks after the onset of bacteremia. Conclusions: This study
demonstrated that additional diagnostic tests should be conducted to
identify metastatic infection, particularly in patients with delayed
antimicrobial treatment, persistent fever and persistently high C-reactive
protein levels.
Key Indexing Terms: Staphylococcus aureus; Bacteremia; Metastatic
infection; Predictive factors. [Am J Med Sci 2015;349(1):24–28.]
S taphylococcus aureus is an important pathogen of blood-stream infection, particularly healthcare-associated and nos-
ocomial bloodstream infections.1,2 Metastatic infection is
a serious complication of both methicillin-sensitive S. aureus
(MSSA) and methicillin-resistant S. aureus bacteremia because
failure in its identiﬁcation may result in bacteremia relapse.
Long-term antibiotic treatment is needed for patients with met-
astatic infections due to S. aureus bacteremia. Hence, metastatic
infections should be detected before antibiotic administration is
completed. Previous studies have shown that the incidence of
metastatic infection due to S. aureus bacteremia ranges between
13% and 39%.3–10 In addition, the predictive factors for meta-
static infection due to S. aureus bacteremia include community
acquisition,11 delay in adequate treatment,12 persistent positive
blood culture results9,11 and persistent fever.11
C-reactive protein (CRP) is a frequently used biomarker
in clinical practice and various studies have evaluated its utility
in bacterial infections. However, few studies have investigated
the role of CRP levels during MSSA bacteremia.9,12 The present
study aimed to determine the predictive factors and evaluate the




The study was conducted at the Jikei University
Hospital, which is a 1,075-bed hospital in Tokyo, Japan. This
study included patients aged 20 years or older whose blood
culture tested positive for MSSA between January 2008 and
December 2012.
Exclusion Criteria
To determine the predictive factors for metastatic
infection due to MSSA bacteremia, patients were excluded
from this study according to the following criteria: polymicro-
bial bacteremia, death or transfer to another hospital within 3
months after the initial positive blood culture result was
obtained.
Study Design
A retrospective cohort study was conducted to evaluate
the predictive factors for metastatic infection due to MSSA
bacteremia. We assessed the following characteristics for each
patient from medical records: age, sex, presence of an
underlying disease, shock status, community acquisition, use
of immunosuppressive agents, neutropenia, CRP levels at the
time of collection of blood samples and after treatment, delay in
antibiotic therapy, persistent fever and primary site of infection.
Definitions
MSSA bacteremia was deﬁned as the identiﬁcation of
MSSA in blood culture and a clinical course consistent with
S. aureus infection. Metastatic infection was deﬁned as deep-
seated infection, including endocarditis and muscle abscess,
detected within 3 months after the initial positive blood culture
result was obtained. Community acquisition was deﬁned as
a positive blood culture result and clinical evidence of infection
that developed within 48 hours after hospital admission if the
patient did not come in contact with any other hospital or clinic.
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Accordingly, 13 patients did not meet the criteria for commu-
nity acquisition because of healthcare-associated infections: pa-
tients who visited an outpatient clinic (7), patients receiving
hemodialysis (4) and patients with a central venous catheter
(2). The source of MSSA bacteremia was determined by com-
parison with other MSSA-positive cultures or a clinical descrip-
tion by the physician in the medical records. Appropriate
antimicrobial treatment was deﬁned as use of antibiotics proven
to be effective in vitro against MSSA isolated from blood cul-
ture. Neutropenia was deﬁned as an absolute neutrophil count
of ,500 cells per cubic millimeter. Patients without any met-
astatic infection were deﬁned as those having bacteremia with-
out any complications such as abscess, spondylitis or relapse of
bacteremia for 3 months after the initial positive blood culture
result. A delay in antibiotic therapy was deﬁned as not receiving
appropriate antimicrobial treatment within 48 hours of a positive
blood culture result.
Microbiological Methods
Blood cultures, each consisting of aerobic and anaerobic
samples, were processed at the clinical laboratory of our
university-afﬁliated hospital. MSSA identiﬁcation and antibiotic
susceptibility tests were performed on a MicroScan WalkAway
96 system (Dade Behring, Inc, West Sacramento, CA). The
Clinical Laboratory and Standards Institute criteria were used to
deﬁne susceptibility or resistance to the antimicrobial agents.
Statistical Analyses
The x2 test or Fisher’s exact test was used to compare
categorical variables; Student’s t test and Mann-Whitney’s U
test were used to compare continuous variables, as needed. To
determine the independent predictive factors for metastatic in-
fections, a multiple logistic regression model was used to con-
trol the effects of confounding variables. Factors that showed
signiﬁcant difference between the present and absent groups
were included in the multiple logistic regression model. The
results of logistic regression analysis were reported as adjusted
odds ratio (AOR) with 95% conﬁdence interval (CI). All
P-values were 2-tailed, and statistical signiﬁcance was set at
P , 0.05. All statistical analyses were performed using IBM
SPSS Statistics 19 (IBM Japan, Ltd, Tokyo, Japan).
RESULTS
Clinical Characteristics of Patients With MSSA
Bacteremia and the Site of Metastatic Infection
One or more cultures of blood specimens from 117
patients were positive for MSSA during the 5-year study period.
Forty-four patients were excluded from the study because of
polymicrobial bacteremia, death or transfer to another hospital
within 3 months after the initial positive blood culture result
was obtained. Finally, 73 patients were included in this study.
Of these, 67.1% (49/73) were men, and the median age of all
patients was 67 years. Fifty patients (68.5%) had an underlying
disease, with diabetes mellitus being the most common (31.5%,
23/73), followed by chronic kidney disease (24.7%, 18/73).
Fourteen patients (19.2%) were infected with MSSA as
a community-acquired infection. Hematological data at the
time of blood culture sampling showed that 5 of 73 patients
(6.8%) had neutropenia (,500 cells/mm3). Metastatic infection
occurred in 14 of 73 patients (19.2%) as follows: muscle
abscess (5, including 4 with psoas abscess), infective endocar-
ditis (3), septic pulmonary abscess (3), spondylodiscitis (4),
epidural abscess (3) and septic arthritis (1). Six patients had
multiple metastatic infections (Table 1), such as muscle abscess
and epidural abscess (2), muscle abscess and septic pulmonary
abscess (1), epidural abscess and spondylodiscitis (1), septic
pulmonary abscess and spondylodiscitis (1) and multiple mus-
cle abscesses (1).
Clinical Features of Patients and Predictive Factors
for Metastatic Infections
We demonstrated the relationship between the clinical
features of patients and metastatic infection (Table 2). Univar-
iate analysis revealed that there was no signiﬁcant difference in
the clinical background between patients with and without met-
astatic infection due to MSSA bacteremia. Furthermore, neu-
tropenia was not associated with metastatic infections. In
TABLE 1. Localization of metastatic infections
Localization Number of patients










Total number of metastatic infections 20








Age, median (range), yr 69 (37–80) 64 (31–95) 0.877
Male gender, n (%) 9 (64.3) 40 (67.8) 0.533
Underlying disease, n (%)
Leukemia 0 (0) 3 (5.1) 0.523
Malignant lymphoma 0 (0) 4 (6.8) 0.418
Solid tumor 2 (14.3) 11 (18.6) 0.524
Diabetic mellitus 2 (14.3) 21 (35.6) 0.108
Chronic kidney disease 2 (14.3) 16 (27.1) 0.264
Liver cirrhosis 1 (7.1) 4 (6.8) 0.667
Shock (systolic blood pressure
, 90 mm Hg)
0 (0) 3 (5.1) 0.523
Community acquisition, n (%) 5 (35.7) 9 (15.3) 0.090
Medication, n (%)
Steroid 3 (21.4) 9 (15.3) 0.415
Immunosuppressive agent 3 (21.4) 13 (22.0) 0.636




0 (0) 5 (8.5) 0.333
CRP . 10 mg/dL 10 (71.4) 16 (27.1) 0.003
CRP, C-reactive protein; MSSA, methicillin-sensitive Staphylococ-
cus aureus.
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contrast, CRP levels of .10 mg/dL at the onset of MSSA
bacteremia were a predictive factor for metastatic infections.
Relationship Between Primary Site of Bacteremia
and Metastatic Infections
The source of infection was identiﬁed in 52 of 73
patients (71.2%) (Table 3). The most common primary site of
infection was catheter-associated bloodstream infection (34.2%,
25/73), followed by skin and soft tissue infection (20.5%, 15/73).
Univariate analysis indicated that the rate of metastatic
infection due to MSSA bacteremia was signiﬁcantly lower in
the patients with central venous catheter-associated bloodstream
infection.
Antibiotic Treatment and Outcome
Appropriate antimicrobial treatment was administered to
62 patients within 48 hours after their blood culture was
obtained. Delay in the administration of appropriate antimicro-
bial treatment was signiﬁcantly higher among patients with
metastatic infection than in those without metastatic infection
(7/14 patients, 50.0% versus 4/59 patients, 6.8%; P 5 0.0004)
(Table 4). In addition, persistent fever for .72 hours after
starting antibiotic treatment was associated with an increased
incidence of metastatic infection. Lowest CRP levels of.3 mg/
dL during 2 weeks after the onset of bacteremia were a predic-
tive factor for metastatic infections.
Among 23 patients who provided blood cultures .48
hours after antibiotic treatment, persistent positive blood cul-
tures were more frequent in those with metastatic infections
(60.0%, 3/5) than in those without metastatic infections
(11.1%, 2/18).
Analyses of Predictive Factors in Logistic
Regression Analysis
The results of univariate analysis revealed that CRP
levels of .10 mg/dL when blood culture was obtained, treat-
ment delay of .48 hours, persistent fever for .72 hours and
lowest CRP levels of .3 mg/dL during 2 weeks after the onset
of bacteremia were signiﬁcantly associated with metastatic
infection. In addition to these variables, diabetes mellitus, com-
munity acquisition and an unknown primary site of MSSA
bacteremia were subjected to multivariate analysis. Multivariate
analysis using the logistic regression model identiﬁed the fol-
lowing independent predictive factors for metastatic infection:
treatment delay (AOR 5 14.041; 95% CI 5 1.934–101.926;
P5 0.009), persistent fever for.72 hours (AOR5 15.631; 95%
CI 5 2.113–115.618; P 5 0.007) and lowest CRP levels of .3
mg/dL after antibiotic treatment (AOR 5 17.95; 95% CI 5
2.736–117.733; P 5 0.003) (Table 5).
DISCUSSION
Although various examinations, including echocardiogra-
phy for endocarditis, computed tomography for septic pulmonary
embolism, magnetic resonance imaging for spondylitis and and
18F-ﬂuorodeoxyglucose-positron emission tomography in com-
bination with low-dose computed tomography are required to
identify metastatic infections, it is difﬁcult to diagnose uncompli-
cated S. aureus bacteremia. Fowler et al deﬁned uncomplicated S.
aureus bacteremia as that in patients with no symptoms or signs
of infection within a 12-week follow-up period.5,11 Similarly, in
this study, we deﬁned uncomplicated S. aureus bacteremia as
that in patients who did not develop metastatic infection within
3 months after the initial positive blood culture result.
In this study, 14 of 73 patients (19.2%) had metastatic
infection due to MSSA bacteremia, which is similar to the
results reported previously.3–8,10 In the study by Cuijpers et al,4
26% of patients with metastatic infection due to S. aureus bac-
teremia did not have localizing signs and symptoms of meta-
static infection. Similarly, in the present study, 33.3% of
patients with metastatic infection did not have localizing signs
and symptoms of metastatic infection. Thus, we should pay
attention to the predictive factors for metastatic infections other
than signs or symptoms.
The time of administration of appropriate antibiotics is
a very important factor affecting the prognosis of S. aureus
bacteremia.12 Paul et al13 demonstrated that compared with pa-
tients receiving appropriate treatment during methicillin-
resistant S. aureus bacteremia, the mortality rate in patients
not receiving appropriate antibiotic treatment within 48 hours
of a positive blood culture result was signiﬁcantly high. Simi-
larly, Bassetti et al14 showed that the administration of inappro-
priate antibiotics was signiﬁcantly associated with high
mortality in patients with S. aureus bacteremia. In addition,









Primary site of infection
Intravascular catheter 1 (7.1) 24 (40.7) 0.140
Central venous catheter 0 (0) 21 (35.6) 0.005
Skin and soft tissue infection 3 (21.4) 12 (20.3) 0.591
Respiratory tract 0 (0) 4 (6.8) 0.418
Urinary tract 3 (21.4) 5 (8.5) 0.175
Unknown 7 (50.0) 14 (23.7) 0.056
MSSA, methicillin-sensitive Staphylococcus aureus.








.48 hours, n (%)
7 (50.0) 4 (6.8) 0.0004
Persistent fever
.72 hours, n (%)
6 (42.9) 5 (8.5) 0.0047
CRP . 3.0 mg/dL 9 (64.3) 19 (32.2) 0.0002
CRP, C-reactive protein.
TABLE 5. Predictive factors of the metastatic infection due to
MSSA bacteremia in the logistic regression analysis
AOR 95% CI P
Treatment delay .48 hours,
n (%)
14.041 1.934–101.926 0.009
Persistent fever .72 hours,
n (%)
15.631 2.113–115.618 0.007
CRP . 3.0 mg/dL 17.95 2.736–117.733 0.003
AOR, adjusted odds ratio; CI, conﬁdence interval; CRP, C-reactive
protein; MSSA, methicillin-sensitive Staphylococcus aureus.
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the present study demonstrated that a delay in appropriate anti-
biotic treatment was a risk factor for metastatic infection due to
MSSA bacteremia. These results suggest that a delay in appro-
priate antibiotic treatment leads to poor prognosis and severe
complications during S. aureus bacteremia.
Guidelines on the diagnosis and management of pros-
thetic joint infections have stated that combination of an
abnormal sedimentation rate and CRP levels seems to provide
the best combination of sensitivity and speciﬁcity.15
Tschaikowsky et al16 showed that presence of high CRP levels
was not a predictive factor for mortality due to bacteremia,
whereas other studies indicated that CRP levels in nonsurvivor
patients were signiﬁcantly higher than those in survivor pa-
tients.17,18 Moreover, Lesens et al9 demonstrated that sustained
bacteremia was signiﬁcantly associated with metastatic infec-
tion and higher frequency of CRP levels of .100 mg/L. Con-
versely, Vos et al12 demonstrated that CRP levels on admission
were not signiﬁcantly different in patients with and without
metastatic infection. Similarly, in the present study, CRP levels
of .10 mg/dL at the onset of MSSA bacteremia were not
signiﬁcantly associated with metastatic infections in logistic
regression analysis, although we observed that this was a pre-
dictive factor for metastatic infections in univariate analysis.
Because a minimum of 2 weeks of antimicrobial
treatment is recommended for adults with uncomplicated
bacteremia, clinicians at our institution determine whether
antimicrobial treatment should be continued or not within
approximately 2 weeks after starting antibiotic administra-
tion.19,20 Therefore, we investigated the lowest CRP levels dur-
ing 2 weeks after the onset of MSSA bacteremia and
demonstrated that lowest CRP levels of .3 mg/dL were signif-
icantly associated with metastatic infection. Welsch et al21 dem-
onstrated that CRP levels in patients with complications were
persistently high after pancreatic resections. These results sug-
gested that persistently high CRP levels were associated with
complications because CRP levels increase after tissue injury.22
Thus, persistently high CRP levels may have an important role
compared with CRP levels at the diagnosis of MSSA bacter-
emia. Therefore, we should aggressively examine for metastatic
infections in patients with unexplained persistently high CRP
levels even after adequate antibiotic treatment.
The most important limitation of this study is that it was
retrospective. CRP levels were not measured serially during the
2-week study. In addition, 5 of 23 patients who provided blood
cultures .48 hours after antibiotic treatment had positive re-
sults; other studies have indicated that persistent positive blood
cultures are signiﬁcantly associated with metastatic infec-
tions.9,11,12 Therefore, we could not conﬁrm whether persistent
positive blood cultures were a predictive factor because blood
cultures were not obtained 48 hours after antibiotic treatment in
all patients. Moreover, in this study, routine transthoracic echo-
cardiography was performed in 28 of 73 patients (38.4%), and
transesophageal echocardiography was performed in only 1
patient. However, 1 patient with metastatic infection did not
have persistent positive blood cultures 48 hours after appropri-
ate antibiotic treatment, and vegetation was not detected with
transthoracic echocardiography. Thus, we could not estimate
the presence of metastatic infections only on the basis of the
results obtained from blood cultures and echocardiography.
In conclusion, metastatic infections may be present in
patients with MSSA bacteremia, although they do not have any
localized symptom or persistent positive bacteremia. Therefore,
we should observe the predictive factors for metastatic
infections, including persistent fever, treatment delay and
persistently high CRP levels.
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